Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum

Clinical trial NCT05979207 · COMPLETED

Trial details

NCT number: NCT05979207
Sponsor: Medicines for Malaria Venture
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections Vector Borne Diseases Systemic Inflammatory Response Syndrome Inflammation Pathologic Processes Malaria Malaria,Falciparum Parasitemia Parasitic Diseases Protozoan Infections Antimalarials Anti-Infective Agents

Start date: 2023-08-01
Primary completion: 2023-10-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.